Graham Corporation (NYSE:GHM ) Q4 2025 Earnings Conference Call June 9, 2025 11:00 AM ET Company Participants Christopher J. Thome - Chief Accounting Officer, VP of Finance, CFO & Corporate Secretary Daniel J.
Graham (GHM) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.12 per share a year ago.
I use YCharts' Value Score and Ben Graham Formula to identify large-cap stocks offering strong value relative to profits, assets, and dividends. Eighteen of twenty-four 'safer' lowest-priced Dividend Dogs of the GVAS are fair-priced and ready to buy for income-focused investors. Top ten GVAS stocks are projected to deliver 17.99% to 68.74% net gains by May 2026, with average risk 29% below the market.
Featuring Executive Chairman, Craig Dalziel and President, Ian Graham Featuring Executive Chairman, Craig Dalziel and President, Ian Graham
Graham Corporation's robust balance sheet, with no debt and $30M net cash, offers financial flexibility and security within the debt-laden Russell 2000 index. Its financial growth is among the small-cap minority. Originally a cyclical petrochemical and energy business, it has completely transformed over two decades and is a big beneficiary of key government spending now (Defence and Space). Its segments show huge promise over the long term, and in the near term, its backlog is 2x its current revenues.
Graham Corporation hasn't gotten off to the greatest start this year, and is down by 23%, underperforming its peers from the Russell 2000 and the industrial sector. Much of the weakness has been triggered by the Q3 results, and also some concerns over global shipbuilding momentum. Despite current weakness, GHM's long-term growth prospects remain strong, with healthy revenue growth, and sturdy margin expansion on the cards.
VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) announces with tremendous sadness the passing of our fellow director and colleague, Graham Wheelock. Graham served on K92's Board of Directors continuously from February 2016, having been appointed to the Board of K92 when the Company first began trading in 2016.
BATAVIA, N.Y.--(BUSINESS WIRE)--Graham Corporation (NYSE: GHM) (“GHM” or “the Company”), a global leader in the design and manufacture of mission critical fluid, power, heat transfer, and vacuum technologies for the defense, space, energy, and process industries, today announced a strategic investment to support the implementation of new Radiographic Testing (“RT”) equipment at Graham's Batavia, New York facility. The investment of $2.2 million, from one of GHM's customers, will enhance the Com.
ARLINGTON, Va.--(BUSINESS WIRE)--Graham Holdings Company (NYSE: GHC) will hold its 2025 Annual Meeting of Shareholders in-person on May 6, 2025 at 8:30 am (ET). The meeting will also be accessible by webcast. Information on the meeting and presentation materials are on the Company's website at www.ghco.com. Shareholders planning to attend the 2025 Annual Meeting of Shareholders of Graham Holdings Company in person or via webcast are required to register in advance here. Questions may be submitt.
The Large Cap Value and Ben Graham Formula strategies identify undervalued, stable stocks with strong fundamentals and low valuations, ideal for long-term investment. Analysts project significant gains (28.24% to 85.64%) from top-ten GASV Dogs by March 2026, based on dividend yields and target prices. Thirteen of nineteen "safer" GASV Dogs are recommended buys, offering reliable dividends and fair pricing relative to their intrinsic value.
TROY, Mich. , March 24, 2025 /PRNewswire/ -- Graham Healthcare Group, a subsidiary of Graham Holdings Company (NYSE: GHC) has announced it has earned the USA TODAY Top Workplaces USA 2025 award.
MONHEIM, Germany--(BUSINESS WIRE)--Bayer announced today that Dr. Mike Graham will become the new Head of Research & Development (R&D) for Bayer's Crop Science division and serve as member of the Leadership Team. He will succeed Dr. Robert Reiter who has decided to retire after 27 years with the company and 34 years in the industry. In his current role, Mike Graham is leading the company's Plant Breeding organization and has profound expertise in R&D and agriculture. The change will.